Certified by Founder Lodge
En Carta Diagnostics
France - Paris
START UP
1 Disclosed Funding Rounds $1,623,697
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Diagnostics for Better care, Everywhere.
En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2024 | Pre-Seed | $1,623,697 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Iridius | $8,600,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Audion | $15,000,000 | (Apr 28, 2026)
